Exact Mass: 289.1525

Exact Mass Matches: 289.1525

Found 36 metabolites which its exact mass value is equals to given mass value 289.1525, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

3-Methylglutarylcarnitine

(3R)-3-{[(3R)-4-carboxy-3-methylbutanoyl]oxy}-4-(trimethylazaniumyl)butanoic acid

C13H23NO6 (289.1525)


3-Methylglutarylcarnitine is an acylcarnitine. More specifically, it is an methylglutaric acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methylglutarylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-methylglutarylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular 3-methylglutarylcarnitine is elevated in the blood or plasma of individuals with psoriasis (PMID: 33391503), CVD (PMID: 32376321), Norman-Roberts syndrome (PMID: 15083694), type 2 diabetes Mellitus (PMID: 20111019, PMID: 19369366, PMID: 29436377), carnitine palmitoyl-trasferase 2 deficiency (PMID: 9657346), Familial Mediterranean Fever (PMID: 29900937), multiple acyl coenzyme A dehydrogenase Deficiency (PMID: 30510944), CVD in type 2 diabetes Mellitus (PMID: 32431666), and gestational diabetes mellitus (PMID: 29436377). It is also decreased in the blood or plasma of individuals with Celiac disease (PMID: 16425363). 3-Methylglutarylcarnitine is elevated in the urine of individuals with medium-chain acyl-CoA dehydrogenase deficiency (PMID: 1635814, PMID: 2246856). 3-Methylglutarylcarnitine is a diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. It is also identified in the urine of patients with Reye-like syndrome (PMID: 3958190 , 10927963 ). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. 3-Methylglutarylcarnitine is a diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. It is also identified in the urine of patients with Reye like syndrome. (PMID 3958190; 10927963) [HMDB] 3-Methylglutarylcarnitine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=102673-95-0 (retrieved 2024-07-10) (CAS RN: 102673-95-0). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

4-Ethoxy-4-oxobutanoylcarnitine

3-[(4-ethoxy-4-oxobutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO6 (289.1525)


4-Ethoxy-4-oxobutanoylcarnitine is an acylcarnitine. More specifically, it is an 4-ethoxy-4-oxobutanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Ethoxy-4-oxobutanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Ethoxy-4-oxobutanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Caryophyllen-beta

3-[(5-Carboxypentanoyl)oxy]-4-(trimethylammonio)butanoic acid

C13H23NO6 (289.1525)


   

4,6-Dideoxy-3-C-methyl-4-(methuylamino)mannose,9CI-Me glycoside, N,2-di-Ac

4,6-Dideoxy-3-C-methyl-4-(methuylamino)mannose,9CI-Me glycoside, N,2-di-Ac

C13H23NO6 (289.1525)


   

Adipoyl-carnitine; AIF; CE0; CorrDec

Adipoyl-carnitine; AIF; CE0; CorrDec

C13H23NO6 (289.1525)


   

Adipoyl-carnitine; AIF; CE10; CorrDec

Adipoyl-carnitine; AIF; CE10; CorrDec

C13H23NO6 (289.1525)


   

Adipoyl-carnitine; AIF; CE30; CorrDec

Adipoyl-carnitine; AIF; CE30; CorrDec

C13H23NO6 (289.1525)


   

Adipoyl-carnitine; AIF; CE0; MS2Dec

Adipoyl-carnitine; AIF; CE0; MS2Dec

C13H23NO6 (289.1525)


   

Adipoyl-carnitine; AIF; CE10; MS2Dec

Adipoyl-carnitine; AIF; CE10; MS2Dec

C13H23NO6 (289.1525)


   

Adipoyl-carnitine; AIF; CE30; MS2Dec

Adipoyl-carnitine; AIF; CE30; MS2Dec

C13H23NO6 (289.1525)


   

Adipoyl-carnitine; LC-tDDA; CE10

Adipoyl-carnitine; LC-tDDA; CE10

C13H23NO6 (289.1525)


   

Adipoyl-carnitine; LC-tDDA; CE20

Adipoyl-carnitine; LC-tDDA; CE20

C13H23NO6 (289.1525)


   

Adipoyl-carnitine; LC-tDDA; CE30

Adipoyl-carnitine; LC-tDDA; CE30

C13H23NO6 (289.1525)


   

Adipoyl-carnitine; LC-tDDA; CE40

Adipoyl-carnitine; LC-tDDA; CE40

C13H23NO6 (289.1525)


   

3-Methylglutarylcarnitine

3-Methylglutarylcarnitine

C13H23NO6 (289.1525)


   

CAR 6:1;O2

3-[(5-carboxypentanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO6 (289.1525)


   
   

Boc-D-Asp(OtBu)-OH

Boc-D-Asp(OtBu)-OH

C13H23NO6 (289.1525)


   

ethyl N-(ethoxycarbonyl)-N-(3-ethoxy-3-oxopropyl)-beta-alaninate

ethyl N-(ethoxycarbonyl)-N-(3-ethoxy-3-oxopropyl)-beta-alaninate

C13H23NO6 (289.1525)


   
   

boc-d-2-aminosuberic acid

boc-d-2-aminosuberic acid

C13H23NO6 (289.1525)


   

Boc-L-aspartic acid 4-tert-butylester

Boc-L-aspartic acid 4-tert-butylester

C13H23NO6 (289.1525)


   

Boc-D-Asp-OtBu

Boc-D-Asp-OtBu

C13H23NO6 (289.1525)


   

4-(5,5-dimethyl-1,3-dioxan-2-yl)piperidine oxalate

4-(5,5-dimethyl-1,3-dioxan-2-yl)piperidine oxalate

C13H23NO6 (289.1525)


   

(3R)-3-[(5-carboxypentanoyl)oxy]-4-(trimethylazaniumyl)butanoate

(3R)-3-[(5-carboxypentanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO6 (289.1525)


   

Methylglutaryl-L-carnitine

Methylglutaryl-L-carnitine

C13H23NO6 (289.1525)


   

4-Ethoxy-4-oxobutanoylcarnitine

4-Ethoxy-4-oxobutanoylcarnitine

C13H23NO6 (289.1525)


   

3-[(4-Carboxy-3-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

3-[(4-Carboxy-3-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H23NO6 (289.1525)


   

O-3-methylglutaryl-L-carnitine

O-3-methylglutaryl-L-carnitine

C13H23NO6 (289.1525)


An O-acyl-L-carnitine that is L-carnitine having a 3-methylglutaryl group as the acyl substituent

   

O-adipoylcarnitine

O-adipoylcarnitine

C13H23NO6 (289.1525)


An O-acylcarnitine compound having adipoyl as the acyl substituent.

   

O-3-Methylglutarylcarnitine

O-3-Methylglutarylcarnitine

C13H23NO6 (289.1525)


An O-methylglutarylcarnitine compound having 3-methylglutaryl as the acyl substituent.

   

O-methylglutarylcarnitine

O-methylglutarylcarnitine

C13H23NO6 (289.1525)


An O-acylcarnitine in which the acyl group specified is methylglutaryl.

   

O-Adipoyl-L-carnitine

O-Adipoyl-L-carnitine

C13H23NO6 (289.1525)


An O-acyl-L-carnitine in which the acyl group specified is adipoyl.

   

CAR DC5:0;3Me

CAR DC5:0;3Me

C13H23NO6 (289.1525)